Mayo Clinic
From the National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital (M.F., J.D.G.), and Richmond Pharmacology (J.T.), London, and the Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow
New England Journal of Medicine | August 30, 2024 | Volume: 392 | Issue: 1 | Pages: 33-44